Physician profile

Benjamin G Farley

Family Medicine · Staunton, VA

NPI 1275505802

$452.59

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$293.29
Travel and Lodging$35.22

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Encore Medical, LP $220.99 2024 Djo Surgical
Amarin Pharma, INC. $111.79 2019
Medshape, INC. $57.62 2024 Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm
Trilliant Surgical LLC. $35.22 2024 Arsenal Sinus Support Plate
Astellas Pharma US INC $14.68 2024 Veozah
Genentech USA, INC. $12.29 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Benjamin G Farley

$452.59

in general payments reported 2019-2025

Years
2019-2024
Top company
Encore Medical, LP

https://glasscript.com/doctor/57641/benjamin-g-farley

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.